Cargando…

Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer

OBJECTIVES: The most common subtype of thyroid cancer is papillary thyroid cancer (PTC); lymph node metastases are common in this disease. Factors affecting the development of central lymph metastasis of PTC determine the treatment modality and prognosis of the disease. In this study, we aimed to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Caliskan, Ozan, Unlu, Mehmet Taner, Aygun, Nurcihan, Kostek, Mehmet, Uludag, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Med Bull Sisli Etfal Hosp 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580980/
https://www.ncbi.nlm.nih.gov/pubmed/36304220
http://dx.doi.org/10.14744/SEMB.2022.32492
_version_ 1784812514766225408
author Caliskan, Ozan
Unlu, Mehmet Taner
Aygun, Nurcihan
Kostek, Mehmet
Uludag, Mehmet
author_facet Caliskan, Ozan
Unlu, Mehmet Taner
Aygun, Nurcihan
Kostek, Mehmet
Uludag, Mehmet
author_sort Caliskan, Ozan
collection PubMed
description OBJECTIVES: The most common subtype of thyroid cancer is papillary thyroid cancer (PTC); lymph node metastases are common in this disease. Factors affecting the development of central lymph metastasis of PTC determine the treatment modality and prognosis of the disease. In this study, we aimed to evaluate the clinicopathologic features affecting the development of central lymph node metastasis. METHODS: The data of a total of 346 PTC patients who were operated between May 2012 and September 2020 in our clinic and whose follow-up could be reached were evaluated retrospectively. Demographic data, surgical treatment modalities, and histopathological data of all patients were evaluated as a result of at least 6 months of follow-up. Patients age, sex, body mass index, pre-operative TSH levels, anti-TPO, and anti-Tg values at the time of diagnosis, whether lymph node dissection is performed, presence of lymph node metastasis, presence of distant metastasis, stage at the time of diagnosis (TNM 8th edition), ATA risk group at the time of diagnosis, multifocal and/or multicentric (bilaterality), largest tumor size, aggressive histological subtype, lymphovascular invasion of the tumor, extrathyroidal invasion, presence of lymphocytic thyroiditis, and surgical margin positivity were evaluated retrospectively. RESULTS: In the development of PTC central metastasis, distant metastasis, tumor size, multifocality, multicentricity, presence of lymphovascular invasion, aggressive tumor subtype, presence of lateral metastasis, nodular goiter, and extrathyroidal spread were found to be effective. Among these factors, T stage, presence of lymphovascular invasion, and multicentricity were identified as independent risk factors for the development of central metastasis. CONCLUSION: Today, the investigation of predictive factors for the development of nodal metastasis in PTC does not seem to be out of date anytime soon. In our study, T stage, presence of lymphovascular invasion, and multicentricity were identified as independent risk factors for the development of central metastasis from the histopathological features of the tumor in PTC and of these features, T stage and multicentricity can be predicted by pre-operative imaging in many patients and can be used to decide whether to perform prophylactic SLN dissection in patients. However, new studies are still needed on this issue, in the literature.
format Online
Article
Text
id pubmed-9580980
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Med Bull Sisli Etfal Hosp
record_format MEDLINE/PubMed
spelling pubmed-95809802022-10-26 Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer Caliskan, Ozan Unlu, Mehmet Taner Aygun, Nurcihan Kostek, Mehmet Uludag, Mehmet Sisli Etfal Hastan Tip Bul Original Research OBJECTIVES: The most common subtype of thyroid cancer is papillary thyroid cancer (PTC); lymph node metastases are common in this disease. Factors affecting the development of central lymph metastasis of PTC determine the treatment modality and prognosis of the disease. In this study, we aimed to evaluate the clinicopathologic features affecting the development of central lymph node metastasis. METHODS: The data of a total of 346 PTC patients who were operated between May 2012 and September 2020 in our clinic and whose follow-up could be reached were evaluated retrospectively. Demographic data, surgical treatment modalities, and histopathological data of all patients were evaluated as a result of at least 6 months of follow-up. Patients age, sex, body mass index, pre-operative TSH levels, anti-TPO, and anti-Tg values at the time of diagnosis, whether lymph node dissection is performed, presence of lymph node metastasis, presence of distant metastasis, stage at the time of diagnosis (TNM 8th edition), ATA risk group at the time of diagnosis, multifocal and/or multicentric (bilaterality), largest tumor size, aggressive histological subtype, lymphovascular invasion of the tumor, extrathyroidal invasion, presence of lymphocytic thyroiditis, and surgical margin positivity were evaluated retrospectively. RESULTS: In the development of PTC central metastasis, distant metastasis, tumor size, multifocality, multicentricity, presence of lymphovascular invasion, aggressive tumor subtype, presence of lateral metastasis, nodular goiter, and extrathyroidal spread were found to be effective. Among these factors, T stage, presence of lymphovascular invasion, and multicentricity were identified as independent risk factors for the development of central metastasis. CONCLUSION: Today, the investigation of predictive factors for the development of nodal metastasis in PTC does not seem to be out of date anytime soon. In our study, T stage, presence of lymphovascular invasion, and multicentricity were identified as independent risk factors for the development of central metastasis from the histopathological features of the tumor in PTC and of these features, T stage and multicentricity can be predicted by pre-operative imaging in many patients and can be used to decide whether to perform prophylactic SLN dissection in patients. However, new studies are still needed on this issue, in the literature. Med Bull Sisli Etfal Hosp 2022-09-22 /pmc/articles/PMC9580980/ /pubmed/36304220 http://dx.doi.org/10.14744/SEMB.2022.32492 Text en ©Copyright 2022 by The Medical Bulletin of Sisli Etfal Hospital - Available online at www.sislietfaltip.org https://creativecommons.org/licenses/by-nc/4.0/OPEN ACCESS This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ). This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Research
Caliskan, Ozan
Unlu, Mehmet Taner
Aygun, Nurcihan
Kostek, Mehmet
Uludag, Mehmet
Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer
title Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer
title_full Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer
title_fullStr Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer
title_full_unstemmed Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer
title_short Predictive Factors Affecting the Development of Central Lymph Node Metastasis in Papillary Thyroid Cancer
title_sort predictive factors affecting the development of central lymph node metastasis in papillary thyroid cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580980/
https://www.ncbi.nlm.nih.gov/pubmed/36304220
http://dx.doi.org/10.14744/SEMB.2022.32492
work_keys_str_mv AT caliskanozan predictivefactorsaffectingthedevelopmentofcentrallymphnodemetastasisinpapillarythyroidcancer
AT unlumehmettaner predictivefactorsaffectingthedevelopmentofcentrallymphnodemetastasisinpapillarythyroidcancer
AT aygunnurcihan predictivefactorsaffectingthedevelopmentofcentrallymphnodemetastasisinpapillarythyroidcancer
AT kostekmehmet predictivefactorsaffectingthedevelopmentofcentrallymphnodemetastasisinpapillarythyroidcancer
AT uludagmehmet predictivefactorsaffectingthedevelopmentofcentrallymphnodemetastasisinpapillarythyroidcancer